about
Functional changes of the basal ganglia circuitry in Parkinson's disease.Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot studyAdenosine receptors and L-DOPA-induced dyskinesia in Parkinson's disease: potential targets for a new therapeutic approach.Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine.Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.A(2A) Receptor Antagonism and Dyskinesia in Parkinson's DiseaseInefficient DNA Repair Is an Aging-Related Modifier of Parkinson's Disease.Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.The 6-hydroxydopamine model: news from the past.Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease.Neural and immune mechanisms in the pathogenesis of Parkinson's disease.Dopamine receptor agonists for Parkinson's disease.A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease.Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease.Toxic profile of bergamot essential oil on survival and proliferation of SH-SY5Y neuroblastoma cells.Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular LayerNeuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia.Selective stimulation of striatal dopamine receptors of the D1- or D2-class causes opposite changes of fos expression in the rat cerebral cortex.Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.Enteric Dysfunctions in Experimental Parkinson's Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats.Autoradiographic study of mitochondrial complex I and glutamate receptors in the basal ganglia of rats after unilateral subthalamic lesion.Blockade of subthalamic glutamatergic activity corrects changes in neuronal metabolism and motor behavior in rats with nigrostriatal lesions.Quantitative study of mitochondrial complex I in platelets of parkinsonian patients.The origin recognition complex subunit, ORC3, is developmentally regulated and supports the expression of biochemical markers of neuronal maturation in cultured cerebellar granule cells.Long-term culture and differentiation of CNS precursors derived from anterior human neural rosettes following exposure to ventralizing factors.Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease.Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease.Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's disease.Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type.Insulin receptor β-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory.Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect.Effects of CGRP receptor antagonism in nitroglycerin-induced hyperalgesia.Calcium homeostasis is dysregulated in parkinsonian patients with L-DOPA-induced dyskinesias.Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease.Activation of brain metabolism and fos during limbic seizures: the role of locus coeruleus.Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats.Peripheral levels of BDNF and NGF in primary headaches.Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease.
P50
Q33924857-F340FC03-8928-44DF-8FE3-8206E07BD0EAQ34427704-61A7FE77-8EB5-49CD-B352-381A5206474FQ35652332-E7B46242-9697-404D-8D70-470C9B706C63Q35952529-3675D710-9699-4639-9C3B-C25760A92CCDQ35975405-16B583EA-CE50-4A67-A05B-3FDACF21E5E4Q36057652-F3D20869-901D-4B47-AB05-7DD557895E4FQ36968940-84CFDBF5-3158-49D1-9C6C-5162B6BB7750Q37002601-5D4AEBA0-F900-45E7-A0B7-3D8D1F6126F6Q37205351-289E0227-5BEA-4BE5-86B7-2475E3B0358DQ37700238-1B576E41-F600-416E-8F89-8A62E445B48FQ38078895-03D9A937-FD53-4714-ABFC-6AD903109B73Q38169202-BC88CAB0-B0A2-4E63-B428-3F85490E784EQ38174986-2FA24E51-AA92-4699-9F9D-1CB9391FF0D9Q38912869-C1B3299A-480C-4423-A1AB-0BAC65E76091Q39008496-D393C95C-2A7D-4C97-AC54-109E64683BE4Q39482147-10DEEF2B-4522-43B3-916D-055C4C751ACAQ41024719-ADC950E1-C876-432C-9063-37A7A1B52172Q41758996-DD26AED7-734D-4F25-B5D8-3D86ADC06C65Q42437472-2078F002-0892-4633-A2B0-48A479368598Q42478628-862AD3DF-96C6-4AAA-B8D4-6646488E35D3Q42485284-116FC6BE-36AA-4148-B2EA-BEE47BA604FAQ42486558-EC6D04B3-009E-4ED4-B981-E91CC47369A3Q42508137-C1CA02BB-B0D7-4D67-BB2F-F7EACE0D542CQ42545281-FF2BDFB6-782F-4B13-B529-36972F7E5AC6Q42950711-11D688B3-25E3-4591-83B6-58C87C503992Q43156073-5781B318-C65B-454B-8AB5-1D3686C7B875Q43234179-55827663-F173-4DE6-89CA-3DA2F773C7DCQ43260033-9FEAE40B-5311-426D-B66A-6B7ED7605CE5Q44536578-426A100D-02DD-4A16-B7F0-B94C6EEADD97Q44642317-392C0BBA-5E40-4BC8-957E-D9DAED5B5497Q44745912-28169B16-8B1F-45C1-8078-58D5C0039612Q44765030-A05438E6-8DBC-4FBB-B284-CB3F07E12FB6Q44863319-71810E60-ACDC-4EAF-99CE-E8C9B487D622Q46010921-E2F48C7A-9D65-4085-B0E0-EE7320FC447CQ46268948-CC1C08FD-4F06-41E1-ABED-528ABADFCC5AQ46635405-9B22FCD7-40C3-4BC9-A10D-D640E217E3B6Q46658978-1C342103-EB15-4945-8BF8-2AEEE718E16DQ46738722-C120DC59-C2FF-4590-9898-E1B6EC1E0B92Q46903587-42BBBB39-78C4-4E70-81D5-05C1DDC545CFQ46953300-258575E8-F7B7-4909-A369-90F2E8BC2297
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fabio Blandini
@ast
Fabio Blandini
@en
Fabio Blandini
@es
Fabio Blandini
@nl
Fabio Blandini
@sl
type
label
Fabio Blandini
@ast
Fabio Blandini
@en
Fabio Blandini
@es
Fabio Blandini
@nl
Fabio Blandini
@sl
altLabel
F Blandini
@en
prefLabel
Fabio Blandini
@ast
Fabio Blandini
@en
Fabio Blandini
@es
Fabio Blandini
@nl
Fabio Blandini
@sl
P1053
J-2658-2016
P106
P1153
7006705152
P21
P31
P3829
P496
0000-0002-0178-1289